Orbimed Advisors LLC Infla Rx N.V. Transaction History

Orbimed Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.83 - $4.48 $1.6 Million - $3.92 Million	-875,297 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$2.35 - $5.58 $443,729 - $1.05 Million	-188,821 Reduced 17.74%	875,297 $4.17 Million
Q1 2021 May 17, 2021	BUY	$3.62 - $6.34 $1.84 Million - $3.22 Million	508,093 Added 91.38%	1,064,118 $4.15 Million
Q4 2020 Feb 16, 2021	SELL	$3.82 - $5.32 $467,950 - $651,700	-122,500 Reduced 18.05%	556,025 $2.8 Million
Q2 2020 Aug 14, 2020	SELL	$4.59 - $8.96 $1.79 Million - $3.49 Million	-389,075 Reduced 36.44%	678,525 $3.11 Million
Q1 2020 May 15, 2020	BUY	$2.65 - $6.08 $2.83 Million - $6.49 Million	1,067,600 New	1,067,600 $4.08 Million

12.9M

19.3K

Ticker IFRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,203,800
Market Cap $112M
Description
InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Orbimed Advisors LLC with notifications on news.